Psychedelics, psychoactive substances that alter people's perceptions, mood and thought patterns, have recently shown promise ...

American chess grandmaster Daniel Naroditsky had multiple drugs in his system when he died last year, according to a ...

Research is suggesting that consuming substances like ketamine and MDMA could make it easier to make lifestyle changes, but ...

An unbiased investigation focusing on the mention of Metabo Drops in the context of discussing metabolic health, the types of ...

Maze Therapeutics uses its Compass genetics platform to advance kidney and obesity drugs, with MZE829 Phase 2 data due in ...

AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor being developed for the management of fibromyalgia. Esreboxetine is the SS-enantiomer of racemic reboxetine.

Liposomal berberine is being promoted online as "nature's Ozempic". Doctors explain what it really does, why evidence is ...

ACNP abstracts are available on the conference website and the Company’s poster will be available on the Centessa website at https://investors.centessa.com/events-presentations after the poster ...

New research has discovered that a neural circuit may explain procrastination. Scientists were able to disrupt this ...

The effectiveness of birth control pills depends on regular use, but some dietary supplements may interfere with the function ...

Health Canada can now approve a generic version of those weight loss drugs, which have proven highly effective and popular as ...

Alkermes (ALKS) shifts to fully integrated biopharma, leveraging Vibrance-2, Lybalvi growth, and Avadel buy to de-risk ...